CANNARA BIOTECH INC (LOVE.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:LOVE - CA13765U2002 - Common Stock
1.93 CAD
+0.11 (+6.04%)
We assign a fundamental rating of 6 out of 10 to LOVE. LOVE was compared to 4 industry peers in the Personal Care Products industry. Both the profitability and the financial health of LOVE get a neutral evaluation. Nothing too spectacular is happening here. LOVE is evaluated to be cheap and growing strongly. This does not happen too often!
1. Profitability
1.1 Basic Checks
- LOVE had positive earnings in the past year.
- In the past year LOVE had a positive cash flow from operations.
- Of the past 5 years LOVE 4 years were profitable.
- The reported operating cash flow has been mixed in the past 5 years: LOVE reported negative operating cash flow in multiple years.
1.2 Ratios
- LOVE's Return On Assets of 7.75% is amongst the best of the industry. LOVE outperforms 100.00% of its industry peers.
- With a decent Return On Equity value of 12.79%, LOVE is doing good in the industry, outperforming 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.75% | ||
| ROE | 12.79% | ||
| ROIC | N/A |
ROA(3y)5.61%
ROA(5y)3.4%
ROE(3y)9.61%
ROE(5y)5.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of LOVE (12.18%) is better than 100.00% of its industry peers.
- LOVE's Profit Margin has improved in the last couple of years.
- LOVE has a Gross Margin (16.40%) which is in line with its industry peers.
- In the last couple of years the Gross Margin of LOVE has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 12.18% | ||
| GM | 16.4% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y23.91%
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-23.98%
2. Health
2.1 Basic Checks
- LOVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for LOVE has been increased compared to 1 year ago.
- Compared to 5 years ago, LOVE has more shares outstanding
- LOVE has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.39 indicates that LOVE is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a decent Altman-Z score value of 2.39, LOVE is doing good in the industry, outperforming 75.00% of the companies in the same industry.
- The Debt to FCF ratio of LOVE is 2.76, which is a good value as it means it would take LOVE, 2.76 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 2.76, LOVE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- A Debt/Equity ratio of 0.34 indicates that LOVE is not too dependend on debt financing.
- LOVE's Debt to Equity ratio of 0.34 is amongst the best of the industry. LOVE outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | 2.76 | ||
| Altman-Z | 2.39 |
ROIC/WACCN/A
WACC7.46%
2.3 Liquidity
- LOVE has a Current Ratio of 2.40. This indicates that LOVE is financially healthy and has no problem in meeting its short term obligations.
- LOVE has a Current ratio of 2.40. This is in the better half of the industry: LOVE outperforms 75.00% of its industry peers.
- A Quick Ratio of 0.90 indicates that LOVE may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.90, LOVE is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.4 | ||
| Quick Ratio | 0.9 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 102.15% over the past year.
- Measured over the past years, LOVE shows a very strong growth in Earnings Per Share. The EPS has been growing by 75.27% on average per year.
- LOVE shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.64%.
- Measured over the past years, LOVE shows a very strong growth in Revenue. The Revenue has been growing by 110.79% on average per year.
EPS 1Y (TTM)102.15%
EPS 3Y75.27%
EPS 5YN/A
EPS Q2Q%-43.56%
Revenue 1Y (TTM)30.64%
Revenue growth 3Y43.92%
Revenue growth 5Y110.79%
Sales Q2Q%20.86%
3.2 Future
- Based on estimates for the next years, LOVE will show a very strong growth in Earnings Per Share. The EPS will grow by 41.42% on average per year.
- Based on estimates for the next years, LOVE will show a quite strong growth in Revenue. The Revenue will grow by 14.84% on average per year.
EPS Next Y60%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.54%
Revenue Next 2Y14.84%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 13.79 indicates a correct valuation of LOVE.
- Based on the Price/Earnings ratio, LOVE is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Earnings ratio of 26.94, LOVE is valued a bit cheaper.
- With a Price/Forward Earnings ratio of 11.94, the valuation of LOVE can be described as very reasonable.
- Based on the Price/Forward Earnings ratio, LOVE is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 23.94. LOVE is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.79 | ||
| Fwd PE | 11.94 |
4.2 Price Multiples
- LOVE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LOVE is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.14 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- LOVE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as LOVE's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- LOVE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX-V:LOVE (1/20/2026, 7:00:00 PM)
1.93
+0.11 (+6.04%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-24 2025-11-24
Earnings (Next)01-26 2026-01-26
Inst Owners0.23%
Inst Owner ChangeN/A
Ins Owners27.98%
Ins Owner ChangeN/A
Market Cap183.16M
Revenue(TTM)107.32M
Net Income(TTM)13.08M
Analysts80
Price Target3.57 (84.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)16.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.79 | ||
| Fwd PE | 11.94 | ||
| P/S | 1.71 | ||
| P/FCF | 12.14 | ||
| P/OCF | 9.15 | ||
| P/B | 1.79 | ||
| P/tB | 1.79 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.14
EY7.25%
EPS(NY)0.16
Fwd EY8.37%
FCF(TTM)0.16
FCFY8.24%
OCF(TTM)0.21
OCFY10.93%
SpS1.13
BVpS1.08
TBVpS1.08
PEG (NY)0.23
PEG (5Y)N/A
Graham Number1.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.75% | ||
| ROE | 12.79% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 12.18% | ||
| GM | 16.4% | ||
| FCFM | 14.06% |
ROA(3y)5.61%
ROA(5y)3.4%
ROE(3y)9.61%
ROE(5y)5.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y23.91%
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-23.98%
F-Score7
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | 2.76 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 73.7% | ||
| Cap/Sales | 4.59% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 115.37% | ||
| Current Ratio | 2.4 | ||
| Quick Ratio | 0.9 | ||
| Altman-Z | 2.39 |
F-Score7
WACC7.46%
ROIC/WACCN/A
Cap/Depr(3y)124.47%
Cap/Depr(5y)353.96%
Cap/Sales(3y)9.79%
Cap/Sales(5y)49.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.15%
EPS 3Y75.27%
EPS 5YN/A
EPS Q2Q%-43.56%
EPS Next Y60%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.64%
Revenue growth 3Y43.92%
Revenue growth 5Y110.79%
Sales Q2Q%20.86%
Revenue Next Year16.54%
Revenue Next 2Y14.84%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y55.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year68.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y317.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y87.34%
OCF growth 3YN/A
OCF growth 5YN/A
CANNARA BIOTECH INC / LOVE.CA FAQ
What is the fundamental rating for LOVE stock?
ChartMill assigns a fundamental rating of 6 / 10 to LOVE.CA.
What is the valuation status of CANNARA BIOTECH INC (LOVE.CA) stock?
ChartMill assigns a valuation rating of 7 / 10 to CANNARA BIOTECH INC (LOVE.CA). This can be considered as Undervalued.
What is the profitability of LOVE stock?
CANNARA BIOTECH INC (LOVE.CA) has a profitability rating of 4 / 10.
Can you provide the financial health for LOVE stock?
The financial health rating of CANNARA BIOTECH INC (LOVE.CA) is 6 / 10.
Can you provide the expected EPS growth for LOVE stock?
The Earnings per Share (EPS) of CANNARA BIOTECH INC (LOVE.CA) is expected to grow by 60% in the next year.